1. Home
  2. HOV vs AVXL Comparison

HOV vs AVXL Comparison

Compare HOV & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOV
  • AVXL
  • Stock Information
  • Founded
  • HOV 1959
  • AVXL 2004
  • Country
  • HOV United States
  • AVXL United States
  • Employees
  • HOV N/A
  • AVXL N/A
  • Industry
  • HOV Homebuilding
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • HOV Consumer Discretionary
  • AVXL Health Care
  • Exchange
  • HOV Nasdaq
  • AVXL Nasdaq
  • Market Cap
  • HOV 877.2M
  • AVXL 956.7M
  • IPO Year
  • HOV N/A
  • AVXL N/A
  • Fundamental
  • Price
  • HOV $149.82
  • AVXL $9.09
  • Analyst Decision
  • HOV Sell
  • AVXL Strong Buy
  • Analyst Count
  • HOV 2
  • AVXL 2
  • Target Price
  • HOV $120.00
  • AVXL $44.00
  • AVG Volume (30 Days)
  • HOV 101.2K
  • AVXL 972.2K
  • Earning Date
  • HOV 08-21-2025
  • AVXL 08-12-2025
  • Dividend Yield
  • HOV N/A
  • AVXL N/A
  • EPS Growth
  • HOV N/A
  • AVXL N/A
  • EPS
  • HOV 20.64
  • AVXL N/A
  • Revenue
  • HOV $3,140,315,000.00
  • AVXL N/A
  • Revenue This Year
  • HOV N/A
  • AVXL N/A
  • Revenue Next Year
  • HOV $6.78
  • AVXL N/A
  • P/E Ratio
  • HOV $7.15
  • AVXL N/A
  • Revenue Growth
  • HOV 7.83
  • AVXL N/A
  • 52 Week Low
  • HOV $81.15
  • AVXL $5.03
  • 52 Week High
  • HOV $233.15
  • AVXL $14.44
  • Technical
  • Relative Strength Index (RSI)
  • HOV 56.14
  • AVXL 42.62
  • Support Level
  • HOV $145.10
  • AVXL $8.82
  • Resistance Level
  • HOV $156.01
  • AVXL $9.69
  • Average True Range (ATR)
  • HOV 5.54
  • AVXL 0.55
  • MACD
  • HOV -0.18
  • AVXL 0.01
  • Stochastic Oscillator
  • HOV 68.40
  • AVXL 16.77

About HOV Hovnanian Enterprises Inc.

Hovnanian Enterprises Inc conducts all of its homebuilding and financial services operations . The company designs, constructs, markets, and sells single-family detached homes, attached townhomes and condominiums, urban infill, and active lifestyle homes in planned residential developments. It has two distinct operations: homebuilding and financial services. Its homebuilding operations are divided geographically into three segments; Northeast which includes Delaware, Maryland, New Jersey, Ohio, Pennsylvania, Virginia and West Virginia; Southeast which includes Florida, Georgia and South Carolina; and West which includes Arizona, California and Texas. The firm generates maximum revenue from West Segment.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.

Share on Social Networks: